Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Kalorama: Retail Clinics a Source of Business for IVD, Pharma

Kalorama Information
Posted on: 28 Sep 16

NEW YORK, Sept. 28, 2016 /PRNewswire/ -- With the number of U.S. clinics located within retail locations exceeding 2,000, they have become an important target for IVD products and , according to Kalorama Information.   There is over $200 billion in supplier sales to these centers, Kalorama found its most recent research report.  And this is up from five years ago.   The finding was made in Kalorama Information's most recent report – Retail Clinics 2016.  Kalorama reports on retail clinics in some form every year and it's latest full-length market research study is available at

Retail clinics are small healthcare venues entirely within a retail store, usually staffed by a nurse practitioner in states where the scope of practice permits.  They tend to offer later and weekend hours for busy shoppers and provide routine services.   Retail clinic locations have expanded from 1,605 to 2,215 in the United States between 2011 and 2016, with drug store chains CVS and Walgreens accounting for the largest share of the locations. 

In expanding Kalorama Information finds that the trend is now large enough to be part of manufacturer strategy and a realistic sales target for IVD and pharmaceutical companies. Kalorama said that sales of three types of products to retail clinics – vaccines, POC tests and lab tests reached $240 million in 2015, with vaccines accounting for a greater share than POC tests or laboratory tests. This reflects total annual growth of over 26% per year since 2010, when retail clinics accounted for about $75 million in purchases of these products.

"Point-of-care test makers in particular should be aware of this growing trend," said Bruce Carlson, Publisher of Kalorama Information in a recent webinar. "You see companies like Alere and Roche making products for common ailments that can fit in smaller locales.  They are thinking of urgent care, but also with an eye towards the new venues."

Roche Diagnostics, for instance, has developed the cobas Liat for smaller venues.  The company recently announced that its cobas Strep A, the first molecular PCR test to deliver laboratory quality results in ~15 minutes was "now available for use in physician offices and retail clinics."

Kalorama Information's report, Retail Clinics 2016, contains detailed forecasts of the market, as well as projections, clinic trends and consumer surveys.  The report is available on Kalorama Information's website

Please link any media or news references to our reports or data to  

About Kalorama Information

Kalorama Information, a division of, supplies the latest in independent medical market research in diagnostics, biotech, pharmaceuticals, medical devices and healthcare; as well as a full range of custom research services. Reports can be purchased through Kalorama's website and are also available on and

We routinely assist the media with healthcare topics. Follow us on Twitter, LinkedIn and our blog at  

Bruce Carlson
(212) 807-2622

For more information:

Editor's Details

Mike Wood

Last updated on: 28/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.